Skip to main content
Lyka Labs Ltd. logo

Lyka Labs Ltd. — Investor Relations & Filings

Ticker · LYKALABS ISIN · INE933A01014 LEI · 3358001RHQJBCTT1ER45 BSE.NS Manufacturing
Open in API
Filings indexed 1,205 across all filing types
Latest filing 2020-02-28 Declaration of Voting R…
Country IN India
Listing BSE.NS LYKALABS

About Lyka Labs Ltd.

https://www.lykalabs.com

Lyka Labs Ltd. specializes in the development, manufacture, and marketing of pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company maintains a diverse product portfolio spanning multiple therapeutic categories, including anti-infectives, dermatologicals, cardiovascular agents, and pain management. A significant area of expertise for the organization is lyophilization technology, enabling the production of high-quality injectable formulations. The company operates advanced manufacturing facilities designed to meet international quality standards, supporting its operations in both domestic and global markets. Its core activities encompass the production of various dosage forms such as tablets, capsules, ointments, and sterile injectables, with a particular focus on specialized segments like cephalosporins and critical care medications.

Recent filings

Filing Released Lang Actions
Updates
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Scrutinizer Report related to a secured creditors meeting convened by the National Company Law Tribunal (NCLT) for approval of a merger scheme between Lyka Healthcare Limited and Lyka Labs Limited. It details the voting process, the resolution passed, the cut-off date for voting rights, and the results of the poll. The report is prepared by a practicing company secretary appointed as Scrutinizer. This document is not an annual report, earnings release, or financial statement. It is a formal report on the voting results of a creditors meeting concerning a merger scheme, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is sufficient and contains substantive content, not merely an announcement or certification. Therefore, the appropriate classification is DVA.
2020-02-28 English
Scrutinizer''s Report
Regulatory Filings
2020-02-28 English
Updates
Regulatory Filings Classification · 95% confidence The document text is extremely short (373 characters) and contains only stock exchange addresses and script codes without any substantive financial data, report content, or detailed information. There is no indication of a full report, announcement, or detailed filing. Given the brevity and lack of content, this is likely a regulatory announcement or a placeholder notice rather than a full report or detailed filing. According to the rules, such short and content-light documents fall under Regulatory Filings (RNS) as a fallback category.
2020-02-28 English
Pursuant to Regulation 30 of SEBI ( Listing Obligations and Disclosure Requirements) Regulation, 2015, the proceedings of NCLT Convened Meeting of Secured Creditors of the Company held ....
Regulatory Filings
2020-02-28 English
Reply to Clarification- Financial results
Regulatory Filings
2020-02-26 English
Updates
Regulatory Filings
2020-02-14 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.